135
Views
5
CrossRef citations to date
0
Altmetric
Case Series

Outpatient ertapenem therapy in an ESBL-high-prevalence area: an efficacy, safety, and cost study

, , , , , , , & show all
Pages 111-117 | Published online: 28 Dec 2018

References

  • HawserSPBouchillonSKHobanDJBadalREIn vitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli from patients with intra-abdominal infections worldwide from 2005-2007: results from the SMART studyInt J Antimicrob Agents200934658558819748234
  • Cornejo-DávilaVPalmeros-RodríguezMAUberetagoyena-Tello de MenesesIManagement of complicated urinary tract infections in a referral center in MexicoInt Urol Nephrol201547222923325425439
  • ZhouJSulaimanZLlorinRMPharmacokinetics of ertapenem in outpatients with complicated urinary tract infectionsJ Antimicrob Chemother20142517252124797063
  • TiceADRehmSJDalovisioJRPractice Guidelines for Outpatient Parenteral Antimicrobial Therapy20043816511672
  • BarrDASempleLSeatonRAOutpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 yearsInt J Antimicrob Agents201239540741322445493
  • ChapmanALSeatonRACooperMAGood practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statementJ Antimicrob Chemother20126751053106222298347
  • VolkowF[Outpatient management manual for intravenous therapy for patients with cancer] Manual del Manejo Ambulatorio de la Terapia Intravenosa para el Enfermo con CáncerNoriega Editores UTEHA20011135 Spanish
  • DoiYParkYSRiveraJICommunity-associated extended-spectrum β-lactamase-producing Escherichia coli infection in the United StatesClin Infect Dis201356564164823150211
  • AzapOKArslanHSerefhanoğluKRisk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infectionsClin Microbiol Infect201016214715119689464
  • LauplandKBChurchDLVidakovichJMucenskiMPitoutJDCommunity-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travelJ Infect20085744144818990451
  • SeatonRABarrDAOutpatient parenteral antibiotic therapy: Principles and practiceEur J Intern Med201324761762323602223
  • QureshiZASyedADoiYSafety and efficacy of long-term outpatient ertapenem therapyAntimicrob Agents Chemother20145863437344024709258
  • ParkSHChoiSMLeeDGImpact of extended-spectrum β-lactamase production on treatment outcomes of acute pyelonephritis caused by escherichia coli in patients without health care-associated risk factorsAntimicrob Agents Chemother20155941962196825583722
  • Guía de Práctica Clínica[Diagnosis and Treatment of Pyelonephritis Acute not Complicated in the Adult. Mexico: Ministry of Health] Diagnóstico y Tratamiento de la Pielonefritis Aguda no Complicada en el AdultoMéxico: Secretaría de Salud2014 Available from: http://www.cenetec.salud.gob.mx/contenidos/gpc/catalogoMaestroGPC.html SpanishAccessed December 1, 2014
  • ParkSHChoiSMChangYKThe efficacy of non-carbapenem antibiotics for the treatment of community-onset acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coliJ Antimicrob Chemother201469102848285624928854
  • ChapmanALDixonSAndrewsDLilliePJBazazRPatchettJDClinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspectiveJ Antimicrob Chemother20096461316132419767623
  • PatersonDLKoWCvon GottbergAAntibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamasesClin Infect Dis2004391313715206050
  • LaneMAMarschallJBeekmannSEOutpatient parenteral antimicrobial therapy practices among adult infectious disease physiciansInfect Control Hosp Epidemiol201435783984424915212
  • MuldoonEGSnydmanDRPenlandECAllisonGMAre we ready for an outpatient parenteral antimicrobial therapy bundle? A critical appraisal of the evidenceClin Infect Dis201357341942423572486
  • GilchristMSeatonRAOutpatient parenteral antimicrobial therapy and antimicrobial stewardship: challenges and checklistsJ Antimicrob Chemother201570496597025538169
  • DrydenMSaeedKTownsendRAntibiotic stewardship and early discharge from hospital: impact of a structured approach to antimicrobial managementJ Antimicrob Chemother20126792289229622623629
  • NathwaniDTiceAAmbulatory antimicrobial use: the value of an outcomes registryJ Antimicrob Chemother200249114915411751779
  • OliveiraPRCarvalhoVCCimermanSLimaALMDiretrizes Brasileiras para Terapia Antimicrobiana Parenteral Ambulatorial groupRecommendations for outpatient parenteral antimicrobial therapy in BrazilBraz J Infect Dis201721664865528711455